

















MOLECULAR AND IMMUNOLOGICAL CHARACTERISTICS OF 
















FPSK (M) 2000 6 
MOLECULAR AND IMMUNOLOGICAL CHARACTERISTICS OF 
VIBRIO CHOLERAE AND VIBRIO ALGINOLYTICUS 
By 
V ASANTHAKUMARI NEELA 
Thesis Submitted in Fulfilment of the Requirements for the 
Degree of Master of Science in the Faculty of 
Medicine and Health Sciences 
U niversiti Putra Malaysia 
May 2000 
Dedicated to my husband and daughter 
For their strength and courage. 
11 
III 
Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfilment of 
the requirements for the degree of Master of Science 
MOLECULAR AND IMMUNOLOGICAL CHARACTERISTICS OF 
VIBRIO CHOLERAE AND VIBRIO ALGINOLYTICUS 
By 
V ASANTHAKUMARI NEELA 
May 2000 
Chairman: Dr. Mariana Nor Shamsudin 
Faculty: Medicine and Health Sciences 
Twenty isolates of Vibrio cholerae and four isolates of Vibrio alginolyticus used 
in this study were identified using the conventional biochemical tests. All of the isolates 
were screened for the zonula occludens toxin gene (zot) by the Polymerase Chain 
Reaction (PCR) technique. The 1 083 bp fragment of the zot gene was successfully 
amplified in all the tested isolates. Asymmetry PCR was used as a preliminary detection 
method and later confirmed through the gene probe method to test for the presence of the 
zot gene. Consequently, the zot gene was successfully cloned in pCR 2. 1 TOPO vector 
and sequenced, in which the sequences were 99% homologous to the gene bank 
sequences. 
The genetic distance and the percentage of the similarity between V. cholerae and 
V. alginolyticus isolates were investigated using RAPD-PCR. Thirteen lO-mer 
lV 
oligonucleotide primers of arbitrary sequence were used to amplify the genomic DNA of 
eleven isolates of V cholerae and four isolates of V alginolyticus. These primers 
revealed a total of 1 85 DNA markers with size ranging from 1 00-1 0,000 bp. Three 
primers OP AE- l ,  1 0  and 1 2  produced a distinct banding pattern for V cholerae isolates. 
Therefore, these primers were identified as suitable primers to produce genetic markers 
that could be used as a species-specific diagnostic trait. The overall percentage of the 
similarity range from 4 1  to 89% for V cholerae and 2 1  to 43% for Valginolyticus. In 
addition, the genetic distance ranged from 0.3205 13  to 0.7 1 0843 for V cholerae and 
0.275229 to 0.846774 for V alginolyticus. 
The differences of the LPS profile between three strains of V cholerae (Ogawa, 
Inaba and Bengal) and three strains of V alginolyticus (203, 265 and 1 003) were 
-
demonstrated in the SDS-P AGE. All the strains except for strain 265 of V alginolyticus 
were shown to have high molecular weight bands and indicated that the LPS were 
immunogenic. The effectiveness of the isolated LPS from the three strains of V 
alginolyticus and one strain of V cholerae (Ogawa) to induce antibody production in 
rabbits was determined by using passive haemagglutination (PHA) technique. 
The study on the molecular and immunological characteristics of V cholerae will 
definitely contribute towards the development of a DNA vaccine against cholera and the 
LPS study suggests that the V cholerae isolates are immunogenic indicating the 
suitability of these isolates as potential vaccine component. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia 
sebagai memenuhi keperluan untuk Ijazah Master Sains. 
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Dua puluh isolat Vibrio cholerae dan empat isolat Vibrio alginolyticus yang 
digunakan dalam kajian ini telah dikenalpastikan melalui ujian-ujian biokimia. Gen toxin 
zonula occ1udens (zot) telah dikesan daripada kesemua isolat menggunakan teknik tindak 
balas berantai polimerase (PCR). Bahagian zot gen bersaiz 1083 bp telah diamplifikasi 
dengan jayanya dalam kesemua isolat yang diuji. PCR asimetri digunakan sebagai kaedah 
pengesanan awal dan kemudian disahkan melalui kaedah prob gen untuk mengkaji 
kehadiran gen zot. Seterusnya, gen zot diklon dengan jayanya dalam vektor pCR 2.1 
TOPO dan dijujukan di mana jujukan tersebut adalah 99% homologus dengan jujukan 
gen bank. 
Jarak genetik dan peratus kesamaan di antara V. cholerae dan V. alginolyticus 
isolat telah dikaji menggunakan RAPD-PCR. Tiga belas primer 10-mer oligonukleotid 
VI 
jujukan rawak telah digunakan untuk mengamplikasikan DNA genomik dari sebelas 
isolat V. cholerae dan empat isolat V. alginolyticus. Primer-primer ini telah 
menghasilkan sejumlah 185 penanda DNA dengan saiz yang berada dalam julat 100 -
10,000 bp. Tiga primer OPAE-l, 10 dan 12 menghasilkan corak jalur yang berbeza bagi 
V. cholerae isolat. Oleh itu, primer-primer ini dikenalpasti sebagai primer yang sesuai 
untuk menghasilkan penanda genetik yang boleh digunakan sebagai trait diagnostik untuk 
species yang spesifik. Secara keseluruhannya, peratus kesamaan mempunyai julat dari 
41% hingga 89% bagi V. cholerae dan 21% hingga 43% bagi V. alginolyticus. 
Sementara, jarak genetik pula adalah berjulat dari 0.320513 hingga 0.710843 bagi V. 
cholerae dan 0.275229 hingga 0.846774 bagi V alginolyticus. 
Perbezaan profil LPS di antara tiga strain V. cholerae (Ogawa, Inaba dan Bengal) 
dan tiga V. alginolyticus. (203, 265 dan 1003) didemontrasikan menggunakan SDS­
PAGE. Kesemua strain kecuali strain 265 V. alginolyticus menunjukkan kehadiran jalur 
yang mempunyai berat molekul yang tinggi dan menunjukkan bahawa LPS adalah 
immunogenik. Keberkesanan LPS yang diisolat dari tiga strain V. alginolyticus dan satu 
strain V. cholerae (Ogawa) dalam merangsangkan pengeluaran antibodi dalam amab 
telah ditentukan dengan menggunakan teknik hemaglutinan pasif 
Kajian ke atas molekul dan ciri immunologikal V. cholerae akan menyumbangkan 
ke arah perkembangan DNA vaksin terhadap cholera dan kajian ke atas LPS V. cholerae 
isolat . yang immunogenik menunjukkan isolat ini mempunyai potensi yang sesuai 
sebagai komponen vaksin. 
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The genus Vibrio is the most extensively characterized and medically important 
bacterial group within the family Vibrionaceae and is classified as the "Facultatively 
Anaerobic Gram Negative Rods". Vibrio species which include Vibrio algino/yticus, 
V. cholerae, V. harveyi, V. parahaemolyticus, V. vulnificus and others, are commonly 
found in aquatic environment (Waldor and Mekalanos, 1996). Members of the genus 
Vibrio are short, non-sporing, gram-negative rods that are often curved and actively motile 
by a single polar flagellum. 
Vibrio cholerae is the etiological agent for the severe diarrheal disease cholerae in 
humans, transmitted by water or food. The actual reservoir of V. cholerae is unknown. 
The World Health Organization describes cholera as a tragedy because this theoretically 
"most preventable disease" is one of the top causes of human morbidity and mortality in 
the world (Jiang et aI., 2000). The incidence of cholera is estimated to exceed five million 
cases each year (Tauxe et aI., 1994). 
Historically, 200 serogroups of the V. cholerae have been described based on heat 
stable somatic O-antigen and genetic diversity (Shimada et al., 1994; Yamai et al., 1997) 
and is known as 01 antigen group. Strains of other serogroups are collectively known as 
non-O 1 antigen. The members of this 01 antigen group has been traditionally associated 
with cholerae. The 01 V. cholerae strains are further classified into two biotypes, 
Classical and EI Tor and initially into 3 serotypes, Inaba, Ogawa and Hikojima. Apart 
from Ogawa, Inaba and Hikojima a new serogroup 0139 Bengal has been recorded. An 
epidemic which began in India late in 1992 and spread to several neighboring countries 
was caused by the 0139 Bengal strain (Albert et aI., 1993a; Ramamurthy et al., 1993; 
Nair et aI., 1994). The V. cholerae 0139 strain proved to be genetically similar to 
V. cholerae Oland is hypothesized as having evolved from the strain of the early seventh 
pandemic (Karaolis et al., 1995; Dumontier and Berche, 1998). 
Clinically, V. cholerae 01 and 0139 Bengal strains caused cholerae of 
comparable severity in infected persons (Morris et Gl., 1?95). However, in striking 
contrast to 01 strains, 0139 strains are encapsulated (Johnson et aI., 1994) possessing an 
O-antigen capsule and lipopolysaccharides (Waldor et al., 1994). The LPS of 01 strains 
have a core region substituted with an average of 17 repeat limits of 4-NH2-4, 6-
dideoxymannose, each substituted with 3-deoxy-L-glycerol-tetronic acid (Manning et al., 
1994). The LPS of 0139 strains appears to be an efficiently substituted core 
polysaccharide with only one or two additional sugar moieties (Weintraub et ai., 1994). 
These changes have made 0139 organisms immunologically distinct from the 01 EI Tor 
strains. 
Vibrio cholerae produces a thermolabile enterotoxin, cholerae toxin (CTX$), 
whose action on the mucosal epithelium of the intestine is responsible for the disease 
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cholerae (Rabbani and Greenough, 1990). Although CTX� is responsible for severe 
dehydrating diarrhea associated with V. cholerae, the search for additional enterotoxins 
produced by V. cholerae, which has included the study of genetically engineered CTX� 
deleted V. cholerae, has led to the discovery of a new toxin (Kaper et a/., 1995). The 
zonula occludens toxin (zot) acts on the intestinal tight junctions (zonula occludens) to 
increase intestinal permeability. The genes encoding zot is located immediately next to 
the CTX� gene on a 4.5 kb dynamic region of the V. cholerae chromosome termed the 
core region or virulence cassette (Aidara et a/., 1998). The manifestation of this disease 
is a rapid onset of severe diarrhea or otherwise known as rice watery stool accompanied 
with vomitting. Untreated patient will succumb to death within 24 hrs after the onset of 
the symptoms, as a result of severe dehydration and cardiovascular collapse. 
In recent years, cholerae has become a global health problem and endemic (a 
disease constantly present in a given location or geographical region) in South East Asia, 
Parts of Africa, Latin America and others, where the occurrence of seasonal outbreaks or 
epidemics (the sudden onset of a disease within a given geographical region, for a limited 
period of time) are particularly associated with poverty and poor sanitation (Coppo et aI., 
1995; Echeverria et al., 1995; Tamayo et al., 1997). Seven distinct pandemics (an epidmic 
affecting large number of people in a major geographical area or worldwide) of cholerae 
has occurred where the onset of the first pandemic was in 1817 (Pollitzer 1959). The last 
pandemic began in Sulawesi, Indonesia in 1961 and since then had spread across Asia, 
affecting 19 countries over several years (Kamal, 1974). 
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The laboratory diagnosis of cholerae is normally carried out by morphology, 
physiology, nutrition requirements, antibiotic resistance, biochemical properties, phage 
sensitivity and more recently by DNA based techniques. 
Rapid development in the field of molecular biology has led to an alternative 
DNA-based procedures for the detection of genetic variation- in Vibrio species. A 
Randomly Amplified Polymorphic DNA (RAPD) was developed for the identification and 
differentiation of different species and strains based on the polymorphisms of the genomic 
DNA (Welsh and McClelland, 1 990). RAPD, also known as Arbitarily Primed 
Polymerase Chain Reaction (AP-PCR), is a technique based on the PCR principle. This 
method provides a convenient and rapid assessment of the genetic composition of the 
particular organisms being studied. 
This procedure is unique in which no prior sequence. information of the genomic 
DNA sample is needed and also whole and cell cultures can be used as the source of the 
template DNA (Joshi et al. , 1 99 1 ). In principle, the method employs a single, short 10-
base oligonucleotide primer that binds to any region in the genome bearing the 
complementary sequence initiating the amplification of specific regions of the genome 
with the PCR (Welsh and McClelland, 1 990; Williams et aI. , 1 990; Brauns et al., 1 99 1 ;  
Caeteano-Anolles et a!., 1 99 1 ;  Whitesides and Oliver, 1 997). 
A specific DNA fragment is produced by one individual but not by another can be 
represented as a genetic marker (Williams et at. , 1 990). The advantages of rapid 
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differentiation of strains are with respect to providing any form of treatment to problems 
such as an infection disease. If the strains were similar and closely related to each other, 
this would mean similar treatment can be used for all strains. 
Even though cholera has been around for a long time and an enormous amount of 
information is known about this bacterium as well as the disease, still it remains as a public 
health concern. It is estimated that about 1 20,000 deaths per annum occur due to the 
outbreaks of cholerae world wide, of which majority occurs in children (WHO, 1 995). The 
contributing factors could be due to the emergence of antibiotic resistant strains (Satcher, 
1995), the clonal diversity of the epidemic strains and third factor is due to the lack of 
preventive measures Vaccination is an acceptable and widely need method of prevention 
The first attempt to develop a cholerae vaccine was done more than 1 00 years ago 
by Jaime Ferranclue in 1 884 The initial live attenuated vaccine and killed whole cell 
vaccines (Heyningen, 1 983) developed were not successful, since it was less effective 
against children and also was not effective against more than one serotypes. 
During 1 980's, oral vaccmes consisting of B subunit of cholerae had been 
developed. It provided short-term protection, where the maximum protection is only for 3 
years with several doses. The rate of efficacy decreases from 85% t03 0% over the 3 years. 
This makes it unsuitable for use in large-scale vaccination program. 
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Later, a combination of the whole cells and subunit components like 
lipopolysaccharides (LPS), protein, toxoids and others were constructed as vaccines. 
Although this vaccine had shown encouraging results in preliminary animal studies, these 
vaccine strategies were not successful in preventing outbreaks of cholerae. 
Then came the live attenuated vaccine, that induces rapid immunization, as short 
as 8 days after vaccination. It offers safe protection against classical strains, but was 
unsuccessful against El Tor types. Recent development of live attenuated vaccine against 
El Tor showed protective efficacy of about 83% in some of the cases (Tacket et al., 1 997) . 
All of the above factors indicate an immediate need of developing a safe and 
efficacious vaccine to prevent cholera. This leads to the need of a groundwork study to 
develop a new DNA based vaccine or Recombinant vaccine for cholerae. Basically, a 
DNA vaccine consists of a plasmid DNA encoded wIth an antigenic protein gene. When 
the gene is introduced into the host cells, the protein will be expressed, thus acts as an 
immunogen and will trigger an immune response against the antigen (Caldwell, 1 997). 
The main advantage of a DNA vaccine is that both types of immune responses are induced. 
They are the cellular mediated immune response (CMI) and humoral mediated immune 
response (Hl\.1I). Developing a DNA vaccine against V. cholerae is a very feasible choice 
for the prevention of this disease because of the diversity in the serotypes of the species. 
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